Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05937685 · ClinicalTrials.gov registry record · NA
Reducing Blood Pressure in Patients With High Cardiovascular Risk
A NA study of Hypertension and Stroke, sponsored by University of Southern California.
- Recruiting
- Registry status
- NA
- Development phase
- 546
- Enrollment target
- 4
- Study locations
NCT05937685 is a NA study of Hypertension and Stroke that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 546 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT05937685, a NA study of Hypertension and Stroke, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- NA
- Development phase
- 546 participants
- Enrollment target
- 4
- Study locations
Study Summary
BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services healthcare system. The goal of this clinical trial is to test if this team based program is better at helping people reduce their blood pressure than usual care for people with prior heart attack or stroke. The main questions it aims to answer are: * Do people in the REACH BP program have lower blood pressure at 12 months compared to those getting usual care? * Do people in the REACH BP program have better Life's Essential 8 scores and patient experience compared to those getting usual care?
Conditions Studied
Interventions
- BEHAVIORAL BP REACH Intervention
Study Locations (4)
California
- Rancho Los Amigos National Rehabilitation Center - Downey
- LA General Medical Center - Los Angeles
- Olive View Medical Center - Sylmar
- Harbor UCLA Medical Center - Torrance
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 546 participants |
| Start Date | 2023-09-01 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05937685
The ClinicalTrials.gov registry entry for NCT05937685 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 546 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (84% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which BP REACH Intervention is the first listed.
NCT05937685 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05937685 about?
NCT05937685 is a clinical study titled "Reducing Blood Pressure in Patients With High Cardiovascular Risk". BP-REACH is a study of a team-based (pharmacist and health coach) program for lowering blood pressure for people with a prior stroke or heart attack in the Los Angeles Department of Health Services healthcare system. The goal of this clinical trial is to test if this team based program is better at...
What is the current status of trial NCT05937685?
This trial is currently recruiting. It is a NA study. The enrollment target is 546 participants. The study started on 2023-09-01. Estimated completion is 2026-07.
What conditions does trial NCT05937685 study?
This clinical trial studies the following conditions: Hypertension, Stroke, Myocardial Infarction.
What interventions are being tested in trial NCT05937685?
The interventions under investigation include: BP REACH Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05937685?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05937685 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.